All Type of News
Pharmaceutical makers, wholesalers urged to seek co-existence
Drug wholesalers have actively moved to seek their survival strategy for the attainment of minimal and reasonable drug margin as GlaxoSmithKline and Kyungdong Pharm succeeded in reducing wholesaler margin.
There is...
Physical activity and exercise key to successful weight loss, KFDA says
Despite the fact that the use of pharmacotherapy produced a more rapid initial weight loss, physical activity and exercise are key to successful weight loss and weight loss maintenance, according to the Korea Food and...
Handok, Sanofi-Aventis launch SDM program for diabetic patientsHandok Pharm and Sanofi-Aventis Korea said on March 18 they had a signing ceremony to launch the fifth Staged Diabetes Management (SDM) program under the collaboration with the ...
|
Dongkook wins Korean patent for sustained release formulations of octretide
Dongkook Pharm said on March 18 it won Korean patent for octreotide in sustained release form and its manufacturing method, following its development of octreotide injection last year.
Octreotide (brand name Sandos...
Huons recalls two lots of heparin sodium injection
Huons Corporation is performing a voluntary recall two lots of heparin sodium injections due to incomplete removal of impurities sourced from a Chinese supplier, Yantai Hepu Biological Product Co., the Korea Food and ...
Suspicions mounting over role of KRPIA
Suspicions are growing over the role of the Korea research-based Pharmaceutical Industry Association (KRPIA) as its member companies are overly concerned with importing high-priced medicines only, irrespective of ...
Korean drug makers eyes OTC market
Stimulated by outer negatives affecting Korea's economy, many pharmaceutical firms plan to expand their presence in the domestic OTC market through sales push on field force and price hike.
Pharmaceutical manufactu...
KFDA approves sorafenib for treatment of hepatocellular carcinomaBayer HealthCare announced on March 18 that the Korea Food and Drug Administration has approved its new drug application for an indication for sorafenib (Nexavar) in hepatocellu...
|
Novartis Korea to promote local venture projects
Novartis Korea plans to make its investment on Korea's three venture start-ups this year for joint research and development (R&D) of new drugs and medical technology.
Novartis Korea, the Korea Trade-Investment Prom...
Pharmacists want general reform of drug administration
Representatives from the Korea Pharmaceutical Association called on newly appointed Commissioner Yoon yeo-pyo of the Korea Food and Drug Administration on March 17 and suggested that the health watchdog undertake gene...
